CN1814214A - 一种治疗体形消瘦、体质虚弱的中药组合物及其制备方法 - Google Patents
一种治疗体形消瘦、体质虚弱的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN1814214A CN1814214A CN 200510022102 CN200510022102A CN1814214A CN 1814214 A CN1814214 A CN 1814214A CN 200510022102 CN200510022102 CN 200510022102 CN 200510022102 A CN200510022102 A CN 200510022102A CN 1814214 A CN1814214 A CN 1814214A
- Authority
- CN
- China
- Prior art keywords
- amounts
- chinese medicine
- medicine composition
- adds
- hours
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 48
- 238000000034 method Methods 0.000 title claims abstract description 13
- 239000000203 mixture Substances 0.000 title claims description 13
- 229940079593 drug Drugs 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 239000008187 granular material Substances 0.000 claims abstract description 7
- 239000006187 pill Substances 0.000 claims abstract description 6
- 239000002775 capsule Substances 0.000 claims abstract description 4
- 239000007901 soft capsule Substances 0.000 claims abstract description 3
- 210000000582 semen Anatomy 0.000 claims description 33
- 239000000341 volatile oil Substances 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 241000756943 Codonopsis Species 0.000 claims description 12
- 239000002671 adjuvant Substances 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 8
- 239000000284 extract Substances 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 7
- 241000202807 Glycyrrhiza Species 0.000 claims description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 229920002472 Starch Polymers 0.000 claims description 5
- 238000002481 ethanol extraction Methods 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 239000003921 oil Substances 0.000 claims description 5
- 239000008107 starch Substances 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 4
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- 239000004375 Dextrin Substances 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 238000005516 engineering process Methods 0.000 claims description 3
- 238000005469 granulation Methods 0.000 claims description 3
- 230000003179 granulation Effects 0.000 claims description 3
- 235000019359 magnesium stearate Nutrition 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 2
- 235000010216 calcium carbonate Nutrition 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims 2
- 239000006196 drop Substances 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- 208000003286 Protein-Energy Malnutrition Diseases 0.000 abstract description 4
- 206010026820 marasmus Diseases 0.000 abstract description 4
- 235000008216 herbs Nutrition 0.000 abstract description 2
- 241000530402 Changium Species 0.000 abstract 1
- 239000003390 Chinese drug Substances 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 239000000890 drug combination Substances 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 description 21
- 210000004369 blood Anatomy 0.000 description 16
- 239000008280 blood Substances 0.000 description 16
- 230000037396 body weight Effects 0.000 description 12
- 239000000047 product Substances 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 241000700159 Rattus Species 0.000 description 8
- 230000006870 function Effects 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 6
- 230000036528 appetite Effects 0.000 description 6
- 235000019789 appetite Nutrition 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 230000005856 abnormality Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 229920002527 Glycogen Polymers 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 229940096919 glycogen Drugs 0.000 description 3
- 230000003118 histopathologic effect Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 229940023488 pill Drugs 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 235000019786 weight gain Nutrition 0.000 description 3
- 241000208340 Araliaceae Species 0.000 description 2
- 208000007882 Gastritis Diseases 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 240000005498 Setaria italica Species 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000002489 hematologic effect Effects 0.000 description 2
- 230000000147 hypnotic effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000002252 panizo Nutrition 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 229930182493 triterpene saponin Natural products 0.000 description 2
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010025476 Malabsorption Diseases 0.000 description 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 1
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- 241000612118 Samolus valerandi Species 0.000 description 1
- 235000005775 Setaria Nutrition 0.000 description 1
- 241000232088 Setaria <nematode> Species 0.000 description 1
- 206010058907 Spinal deformity Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 208000009257 Visceral Prolapse Diseases 0.000 description 1
- 206010063840 Visceroptosis Diseases 0.000 description 1
- 241001251949 Xanthium sibiricum Species 0.000 description 1
- 241001247821 Ziziphus Species 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 230000000157 blood function Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000008941 guipiwan Substances 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229940100691 oral capsule Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 1
- 229960003147 reserpine Drugs 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000008925 spontaneous activity Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100221024A CN100493578C (zh) | 2005-11-21 | 2005-11-21 | 一种治疗体形消瘦、体质虚弱的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100221024A CN100493578C (zh) | 2005-11-21 | 2005-11-21 | 一种治疗体形消瘦、体质虚弱的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1814214A true CN1814214A (zh) | 2006-08-09 |
CN100493578C CN100493578C (zh) | 2009-06-03 |
Family
ID=36906646
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100221024A Expired - Fee Related CN100493578C (zh) | 2005-11-21 | 2005-11-21 | 一种治疗体形消瘦、体质虚弱的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100493578C (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103432444A (zh) * | 2013-08-12 | 2013-12-11 | 施瑞客(天津)生物技术有限公司 | 一种猪促生长用的保健中药组合物 |
CN104524323A (zh) * | 2014-11-21 | 2015-04-22 | 黄红霞 | 参苓白术养生中药酒及制备方法 |
CN104877849A (zh) * | 2015-03-30 | 2015-09-02 | 孙村镇中药材种植技术协会 | 一种有助于开胃健脾的部分发酵甘草枸杞汁液及其制备方法 |
CN105685988A (zh) * | 2016-03-04 | 2016-06-22 | 童松 | 一种白术党参茯苓糕及其制备方法 |
CN108450615A (zh) * | 2018-04-20 | 2018-08-28 | 江西中医药大学 | 一种中药抗疲劳养神茶及制备方法 |
-
2005
- 2005-11-21 CN CNB2005100221024A patent/CN100493578C/zh not_active Expired - Fee Related
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103432444A (zh) * | 2013-08-12 | 2013-12-11 | 施瑞客(天津)生物技术有限公司 | 一种猪促生长用的保健中药组合物 |
CN104524323A (zh) * | 2014-11-21 | 2015-04-22 | 黄红霞 | 参苓白术养生中药酒及制备方法 |
CN104877849A (zh) * | 2015-03-30 | 2015-09-02 | 孙村镇中药材种植技术协会 | 一种有助于开胃健脾的部分发酵甘草枸杞汁液及其制备方法 |
CN105685988A (zh) * | 2016-03-04 | 2016-06-22 | 童松 | 一种白术党参茯苓糕及其制备方法 |
CN108450615A (zh) * | 2018-04-20 | 2018-08-28 | 江西中医药大学 | 一种中药抗疲劳养神茶及制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN100493578C (zh) | 2009-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100534474C (zh) | 一种具有增强免疫功效的组合物及其制备方法和其用途 | |
CN102205107B (zh) | 一种治疗十二指肠溃疡的中药制剂及其制备方法 | |
CN102293927B (zh) | 具有抗疲劳和抗氧化功能的复方中药制剂及其制备方法 | |
CN1899342A (zh) | 一种治疗糖尿病的口服药物及其用途 | |
CN106362020B (zh) | 一种具有改善通便作用的松花粉组合物及其制备方法 | |
CN1895547B (zh) | 一种治疗2型糖尿病的药物及制备方法 | |
CN101856405B (zh) | 一种治疗2型糖尿病的药物组合物及其制备方法 | |
CN100493578C (zh) | 一种治疗体形消瘦、体质虚弱的中药组合物及其制备方法 | |
CN107468747A (zh) | 一种有利于抗癌、防癌的人参组合物及其制备方法 | |
CN1471845A (zh) | 一种以灵芝、天麻为原料的保健食品及其制备方法 | |
CN105456689A (zh) | 一种治疗糖尿病的中药组合物及其制备方法和用途 | |
CN102018852A (zh) | 参连消渴降糖胶囊及制作工艺 | |
CN101015655A (zh) | 小儿抗痫药物 | |
CN105769957B (zh) | 一种雪梨米泔水制三七粉及其制剂和制备方法 | |
CN101468173B (zh) | 一种治疗小儿消化不良的中药组合物及其制备方法 | |
CN105250954B (zh) | 一种治疗肠易激综合征的中药及其制备方法 | |
CN103393938B (zh) | 一种降血糖的中药组合物 | |
CN104324134B (zh) | 一种改善微循环的中药组合物及其制备方法 | |
CN103238834B (zh) | 一种治疗皮肤瘙痒的组合物及其制备方法 | |
CN105727089A (zh) | 含艾叶的药物组合物用于制备治疗肠易激综合症药物中的用途 | |
CN102485259A (zh) | 一种人参果药用分散片、含片的制备方法和应用 | |
CN102784230A (zh) | 一种治疗营养性贫血的药物组合物制剂 | |
CN102552677B (zh) | 黄地安消胶囊及其制备方法 | |
CN112336802A (zh) | 一种改善糖尿病糖脂代谢的中药组合物及其应用 | |
CN105055851A (zh) | 一种治疗糖尿病的中药组合物、其制剂及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: ZHEJIANG WEIKANG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: SHI SHENGHONG Effective date: 20100512 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 610031 NO.10, UNIT 2, BUILDING 3, NO.9, MUDIAN ROAD, QINGYANG DISTRICT, CHENGDU CITY, SICHUAN PROVINCE TO: 323000 SHUIGE INDUSTRY DISTRICT, LISHUI CITY ECONOMIC DEVELOPMENT ZONE, ZHEJIANG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20100512 Address after: 323000 Lishui Province Economic Development Zone Zhejiang Shuige Industrial Zone Patentee after: Zhejiang Wecome Medicine lndustry Co., Ltd. Address before: 610031, No. 2, unit 3, 10, circuit 9, Qingyang District, Chengdu, Sichuan Patentee before: Shi Shenghong |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Chinese medicine composition for treating body thin and delicate coustitution, and preparing method Effective date of registration: 20120410 Granted publication date: 20090603 Pledgee: CITIC Bank, Limited by Share Ltd, Lishui branch Pledgor: Zhejiang Wecome Medicine lndustry Co., Ltd. Registration number: 2012990000134 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20140117 Granted publication date: 20090603 Pledgee: CITIC Bank, Limited by Share Ltd, Lishui branch Pledgor: Zhejiang Wecome Medicine lndustry Co., Ltd. Registration number: 2012990000134 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090603 Termination date: 20131121 |